Oklahoma takes CVS Caremark to new PBM court

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without many pharmacy options.
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...
Even as a move to regulate pharmacy benefit managers like Express Scripts gets bipartisan support in Congress, a Missouri ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.